One through line with Trump is his frustration with the free press. In his post-2016 news conference, he assailed CNN as ...

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

The stock's fall snapped a two-day winning streak.

2024 was one of the most eventful years for the pharmaceutical, biotech, life sciences and medical marketing industries.

Cheap stocks are worth considering now due to expected interest rate cuts, potential market rebounds, and substantial upside ...

In this deep dive BioSpace explores the opportunities and challenges presented by the FDA’s accelerated approval program.

Regeneron Pharmaceuticals has settled allegations that it misused a patented protein to test its COVID-19 treatment REGEN-COV ...

Trump touched off a frenzy over RFK Jr. and vaccines — one reporter asked "What about the polio vaccine?" and Trump responded "everything should be looked at." ...

CHARLESTON, W.Va. — West Virginia Attorney General Patrick Morrisey on Thursday said the Circuit Court of Mason County has approved a settlement between the state and pharmaceutical companies Pfizer ...

As of the latest trading close, PFE, a Healthcare sector stock, is trading -18.90% below its 52-week high but remains 4.49% above its 52-week low. The Average True Range (ATR) (14 days) of 0.55 ...

New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...

Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here, BioSpace looks at five ...